Status:
COMPLETED
The Invia Motion at Cesarean Study
Lead Sponsor:
Indiana University
Collaborating Sponsors:
Medela AG
Conditions:
Negative Pressure Wound Therapy
Cesarean Section; Infection
Eligibility:
FEMALE
Phase:
PHASE4
Brief Summary
To assess patient centered outcomes of the Medela INVIA Motion prophylactic NPWT system at cesarean delivery.
Detailed Description
This study will be a two center case series of women undergoing caesarean delivery conducted at two medical centers in Indianapolis, Indiana. All patients meeting inclusion criteria will be included....
Eligibility Criteria
Inclusion
- Scheduled/non-labor or unscheduled/labor cesarean delivery
- Gestational age greater than or equal to 23 weeks
Exclusion
- Unwilling or unable to provide consent
- Non-availability for postoperative follow-up
- Contraindication to NPWT
Key Trial Info
Start Date :
March 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04365452
Start Date
March 10 2020
End Date
December 31 2020
Last Update
May 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana University
Indianapolis, Indiana, United States, 46202